Griseofulvin and Ketoconazole in the Treatment of Dermatophyte Infections

Teignes tondantes, mycoses ungueales et mycoses cutanees extensives ne peuvent habituellement pas etre traitees par un topique seul, mais necessitent le recours a un traitement systemique: soit de la griseofulvine, soit du lectoconazole. L'etude porte sur l'efficacite comparee de ces deux traitements

[1]  S. Sherlock,et al.  Hepatic reactions associated with ketoconazole in the United Kingdom. , 1987, British medical journal.

[2]  T. Bates,et al.  PHARMACOKINETICS OF KETOCONAZOLE-ANTIPYRINE INTERACTION , 1985, The Lancet.

[3]  R. Hay,et al.  A comparative double blind study of ketoconazole and griseofulvin in dermatophytosis , 1985, The British journal of dermatology.

[4]  D. Stevens.  Ketoconazole metamorphosis. An antimicrobial becomes an endocrine drug. , 1985, Archives of internal medicine.

[5]  W. Tucker,et al.  Reversible adrenal insufficiency induced by ketoconazole. , 1985, JAMA.

[6]  E. Svejgaard.  Oral ketoconazole as an alternative to griseofulvin in recalcitrant dermatophyte infections and onychomycosis. , 1985, Acta dermato-venereologica.

[7]  D. Engelhard,et al.  Interaction of ketoconazole with rifampin and isoniazid. , 1984, The New England journal of medicine.

[8]  J. Galgiani,et al.  High-dose ketoconazole therapy and adrenal and testicular function in humans. , 1984, Archives of internal medicine.

[9]  R. Savin.  Systemic ketoconazole in tinea versicolor: a double-blind evaluation and 1-year follow-up. , 1984, Journal of the American Academy of Dermatology.

[10]  J. Weber,et al.  Interaction between oral contraceptives and griseofulvin. , 1984, British medical journal.

[11]  K. Ishak,et al.  Hepatic injury associated with ketoconazole therapy. Analysis of 33 cases. , 1984, Gastroenterology.

[12]  A. Smith.  Potentiation of oral anticoagulants by ketoconazole. , 1984, British medical journal.

[13]  H. Haverkamp,et al.  Anaphylactic reactions to ketoconazole. , 1983, British medical journal.

[14]  D. Bateman,et al.  De novo minor status epilepticus of late onset presenting as stupor. , 1983, British medical journal.

[15]  J. Wishart.  A DOUBLE BLIND TRIAL OF KETOCONAZOLE VERSUS GRISEOFULVIN TREATMENT FOR DERMATOPHYTE INFECTIONS , 1983, The Australasian journal of dermatology.

[16]  R. Glogau,et al.  A multicenter double-blind evaluation of ketoconazole in the treatment of dermatomycoses. , 1983, Cutis.

[17]  P. Janssen,et al.  Hepatic reactions during ketoconazole treatment. , 1983, The American journal of medicine.

[18]  M. De Brabander,et al.  The mechanism of action of the new antimycotic ketoconazole. , 1983, The American journal of medicine.

[19]  J. V. van Cutsem.  The antifungal activity of ketoconazole. , 1983, The American journal of medicine.

[20]  A. Katsambas,et al.  Ketoconazole compared with griseofulvin in dermatophytoses: a randomized, double-blind trial. , 1983, Dermatologica.

[21]  Y. Clayton,et al.  Treatment of chronic dermatophyte infections. The use of ketoconazole in griseofulvin treatment failures , 1982, Clinical and experimental dermatology.

[22]  H. Blank.  Commentary: Treatment of Dermatomycoses With Griseofulvin , 1982 .

[23]  H. Blank.  "The treatment of dermatomycoses with orally administered griseofulvin" by Blank and Roth, March 1959. Commentary: Treatment of dermatomycoses with griseofulvin. , 1982, Archives of dermatology.

[24]  C. Lin,et al.  Comparative Bioavailability of a Microsize and Ultramicrosize Griseofulvin Formulation in Man , 1982, The Journal of international medical research.

[25]  J. Hanifin,et al.  Ketoconazole in griseofulvin-resistant dermatophytosis. , 1982, Journal of the American Academy of Dermatology.

[26]  J. G. Simpson,et al.  Oral ketoconazole. An effective and safe treatment for dermatophytosis. , 1981, Archives of dermatology.

[27]  R. Hay.  Failure of treatment in chronic dermatophyte infections. , 1979, Postgraduate medical journal.

[28]  J. Bianchine,et al.  The bioavailability of ultramicrosize griseofulvin (Gris-PEG) tablets in man. , 1975, Current therapeutic research, clinical and experimental.

[29]  S. Symchowicz,et al.  Absorption, distribution, metabolism, and excretion of griseofulvin in man and animals. , 1975, Drug metabolism reviews.

[30]  Anderson Dw.  GRISEOFULVIN: BIOLOGY AND CLINICAL USEFULNESS. A REVIEW. , 1965, Annals of allergy.

[31]  R. G. Crounse,et al.  Human pharmacology of griseofulvin: the effect of fat intake on gastrointestinal absorption. , 1961, The Journal of investigative dermatology.